Partner Content Partner Content Event Highlights for 13th Annual Industry Leading Cold Chain... Event Highlights - 13th Annual Cold Chain Distribution
Partner Content Partner Content IATA's CEIV-Pharma Certification or HSA's GDP Certification? 13th Cold Chain Distribution Conference
Partner Content Partner Content Latest Updates on 13th Annual Industry Leading Cold Chain Di... 13th Annual Industry Leading Cold Chain Distribution
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
